Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic Variants of Annexin A2 and Cryptogenic Stroke
NCT06880107Recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Apr 2025
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Trial (3 arms), sponsored by CHU Amiens-Picardie. Primary endpoints: Genetic variants of ANXA2 at day 1 and Genetic variants of S100A10 at day 1. Started Apr 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06880107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06880107.